TransCode Therapeutics
IPO, $7M

Spun out of Harvard Medical School, TransCode Therapeutics is a platform delivery company focusing on oncology. TransCode came to MBI in 2021 and while in our incubator, they expanded their team and completed an IPO event. TransCode also launched clinical trials while at MBI. TransCode graduated in 2022 and is now located in Newton, MA. The company continues to grow and recently announced another IPO for $7M.